Chapter 1. DRUG ABUSE TESTING MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. DRUG ABUSE TESTING MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. DRUG ABUSE TESTING MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. DRUG ABUSE TESTING MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. DRUG ABUSE TESTING MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. DRUG ABUSE TESTING MARKET– By Sample Type

6.1. Saliva

6.2. Urine

6.3. Blood

6.4. Other Sample Types

Chapter 7. DRUG ABUSE TESTING MARKET– By Product Type

7.1. Analyzers

       7.1.1. Immunoassay Analyzers

       7.1.2. Chromatographic Devices

       7.1.3. Breath Analyzers

7.2. Rapid Testing Devices

       7.2.1. Urine Testing Devices

       7.2.2. Oral Fluid Testing Devices

7.3. Consumables

Chapter 8. DRUG ABUSE TESTING MARKET– By End-User

8.1. Hospitals

8.2. Diagnostic Laboratories

8.3. Forensic Laboratories

8.4. Other End Users

Chapter 9. DRUG ABUSE TESTING MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. DRUG ABUSE TESTING MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10